Skip to main navigation
logo

Investor Relations

  • Overview
  • News & Events
    • News Releases
    • Scientific Conferences
    • Investor Calendar
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Management
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports & Proxies
    • Quarterly Results
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

05 Jan, 2022
Galecto Adds Experienced Biotech Executive Stephanie Oestreich as Chief Business Officer
Dr. Oestreich brings extensive experience in business and drug development BOSTON , Jan. 05, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the appointment of a

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2

Site - Investor Tools

  • Email Alerts
  • Print Page
  • RSS Feeds
  • Contact IR

© 2022 Galecto All rights reserved.

  • Cookies
  • Privacy Policy